跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

S-008

Supelco

舒芬太尼标准液 溶液

100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C22H30N2O2S · C6H8O7
CAS号:
60561-17-3
分子量:
578.67
EC 号:
200-659-6
MDL编号:
MFCD00072116
UNSPSC代码:
41116107
PubChem化学物质编号:
329824410
NACRES:
NA.24

等级

certified reference material

质量水平

300

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

浓度

100 μg/mL in methanol (as free base)

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

-10 to -25°C

SMILES字符串

OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(=O)N(c1ccccc1)C2(CCN(CCc3cccs3)CC2)COC

InChI

1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

InChI key

OJCZPLDERGDQRJ-UHFFFAOYSA-N

基因信息

human ... OPRM1(4988)

一般描述

舒芬太尼是一种短效合成阿片类镇痛药，最常用于医疗手术中的疼痛缓解。本认证溶液标准适用于临床毒理学、疼痛处方监测或LC-MS/MS或GC/MS法医分析。舒芬太尼以商品名Sufenta出售。

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

A-071

阿芬太尼标准液 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-071

13种疼痛管理混标 溶液, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

F-001

芬太尼-D5标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-002

芬太尼标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-013

芬太尼标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-030

去甲芬太尼-D5标准液 CRM 草酸酯 溶液, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-031

去甲芬太尼标准液 草酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-055

去甲芬太尼-D5标准液 CRM 草酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

S-018

舒芬太尼-D5标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-066

丁酰芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

C-162

卡芬太尼标准液 溶液, (sold as 100 ug/mL in methanol as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-163

卡芬太尼-D5标准液 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-194

(±)-顺-3-甲基芬太尼盐酸盐标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-139

4-ANPP标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-049

全氟芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

I-038

异丁酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

N-114

草酸去甲卡芬太尼 草酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-048

戊酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-140

丙烯酰芬太尼 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

O-047

奥芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-048

对全氟丁酰芬太尼(PFBF)标准液 溶液, 100 μg/mL in methanol (), certified reference material, ampule of 0.5 mL, Cerilliant®

H-130

β羟基硫代芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

D-168

N-去甲基U-47700-D3 溶液, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

D-167

N-去甲基U-47700 溶液, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

F-050

4-氟异丁酰芬太尼标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

A-157

4-ANPP-D5标准液 溶液, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-054

邻全氟芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-200

甲氧乙酰芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-068

戊酰芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-177

环丙芬太尼标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

F-053

呋喃芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-156

卡芬太尼-D5标准液 盐酸盐 溶液, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Robert Stephen et al.
Journal of opioid management, 8(4), 237-241 (2012-09-04)
In emergency medicine, the ability to provide rapid, adequate pain control without high resource utilization is ideal. In this study, the efficacy of intranasal sufentanil in emergency department (ED) patients with acute distal extremity injury was evaluated. A nonrandomized, open-label
J Fechner et al.
European journal of pain (London, England), 17(4), 562-570 (2012-08-29)
There is an ongoing debate whether opioids when used for intra-operative analgesia may enhance post-operative pain. We studied the effect of two different intra-operative dosings of sufentanil on post-operative morphine consumption, pain and hyperalgesia after cardiac anaesthesia. Forty-two male patients
Marc Lilot et al.
Anesthesia and analgesia, 117(1), 259-264 (2013-04-18)
In this randomized, prospective trial, we sought to determine the effective dose of hypobaric ropivacaine with sufentanil providing 95% success (ED95) in spinal anesthesia for traumatic femoral neck surgery in the elderly. Sixty-eight elderly patients with unilateral hip fracture randomly
S Karason et al.
Acta anaesthesiologica Scandinavica, 57(5), 639-645 (2013-02-26)
Bladder catheterisation may be inconvenient for patients, delay mobilisation and risk complications. We hypothesised that by excluding pre-operatively patients at high risk of post-operative urinary retention, the majority of patients could avoid perioperative catheterisation during low-dose spinal anaesthesia. Patients undergoing
Xin Wang et al.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 21(5), 1140-1145 (2012-12-12)
To evaluate the effect of combined local anaesthetic and opioid in post-operative analgesia, the effect of intra-articular injection of local anaesthetic (ropivacaine), opioid (sufentanil) and combination of these two (ropivacaine combined with sufentanil) after the single-bundle anterior cruciate ligament reconstruction
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门